Autoimmune and Inflammatory Disorders
Autoimmune and Inflammatory Disorders is a research topic within Epidemiology. Science Explorer counts 18k research works in it since 1950. 9.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the association between neutrophilic dermatoses, such as Pyoderma Gangrenosum and Sweet's Syndrome, and inflammatory bowel diseases. It covers various aspects including clinical features, treatment strategies, pathophysiology, and potential links with autoinflammatory skin disorders.
- Pyoderma Gangrenosum
- Sweet's Syndrome
- Neutrophilic Dermatosis
- Inflammatory Bowel Disease
- Autoinflammatory Skin Disorders
- Orofacial Granulomatosis
- Erythema Elevatum Diutinum
- Histiocytoid Sweet Syndrome
- Vasculitis
- Granulomatous Cheilitis
- Research works
- 18k fractional, since 1950
- In the world top 10%
- 1.7k per year above
- Top-10% rate
- 9.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +35% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Autoimmune and Inflammatory Disorders research?
By volume, the United States and China publish the most (804 and 255 works in 2022–2025).
By volume, 2022–2025
- 1 United States 804 works
- 2 China 255 works
- 3 India 216 works
- 4 Brazil 169 works
- 5 Japan 162 works
- 6 France 142 works
- 7 Germany 140 works
- 8 Spain 138 works
- 9 United Kingdom 125 works
- 10 Italy 124 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Autoimmune and Inflammatory Disorders research?
By volume in 2022–2025, Oregon Health & Science University publishes the most Autoimmune and Inflammatory Disorders research, followed by Cleveland Clinic and Icahn School of Medicine at Mount Sinai.
By volume, 2022–2025
- 1 Oregon Health & Science UniversityUnited States 17 works
- 2 Cleveland ClinicUnited States 15 works
- 3 Icahn School of Medicine at Mount SinaiUnited States 14 works
- 4 Hopital Universitaire Hedi ChakerTunisia 13 works
- 5 Mayo Clinic in ArizonaUnited States 12 works
- 6 All India Institute of Medical SciencesIndia 11 works
- 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 11 works
- 8 Harvard UniversityUnited States 9 works
- 9 Hôpital Farhat HachedTunisia 9 works
- 10 Yale UniversityUnited States 9 works
Who are the leading researchers in Autoimmune and Inflammatory Disorders?
The most-cited researchers publishing on Autoimmune and Inflammatory Disorders include Mark J. Daly, Winfried März and Peter R. Galle.
- 1 Mark J. Daly United States 9.6k citations
- 2 Winfried März Germany 5.2k citations
- 3 Peter R. Galle Germany 3.3k citations
- 4 Thomas Schwarz United States 3.1k citations
- 5 Ramnik J. Xavier United States 3k citations
- 6 Stefan Schreiber Germany 2.9k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Autoimmune and Inflammatory Disorders research done?
The largest centres of Autoimmune and Inflammatory Disorders research in 2022–2025 are New York (United States), Paris (France), Beijing (China) and São Paulo (Brazil). Among places with at least 20 works in it, it is an unusually large share of all research in Tunis.
Largest cities, 2022–2025
Where it is the local speciality
- TunisTN · 20.3 works9.4×
Location quotient: how much more of its research is in Autoimmune and Inflammatory Disorders than the world average.
Where is the best place to study Autoimmune and Inflammatory Disorders?
Among universities, judged by research, Oregon Health & Science University, Icahn School of Medicine at Mount Sinai and Post Graduate Institute of Medical Education and Research score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Oregon Health & Science UniversityUnited States | 84.5 | 15.0% | 17.9× | 17 | +785.0% |
| 2 | Icahn School of Medicine at Mount SinaiUnited States | 80.6 | 21.6% | 9.0× | 14 | +112.5% |
| 3 | Post Graduate Institute of Medical Education and ResearchIndia | 44.4 | 3.9% | 8.4× | 9 | +199.4% |
| 4 | Yale UniversityUnited States | 40.9 | 8.9% | 2.9× | 9 | +347.6% |
| 5 | All India Institute of Medical SciencesIndia | 40.5 | 7.4% | 5.9× | 12 | +87.5% |
| 6 | Sun Yat-sen UniversityChina | 37.5 | 21.0% | 1.8× | 9 | -10.3% |
| 7 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 36.8 | 11.5% | 3.4× | 10 | +62.2% |
| 8 | Sechenov UniversityRussia | 36.8 | 0.1% | 9.1× | 9 | — |
| 9 | Harvard UniversityUnited States | 33.9 | 11.4% | 2.3× | 9 | +8.3% |
| 10 | Universidade de São PauloBrazil | 30.2 | 13.3% | 1.4× | 8 | +68.9% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Autoimmune and Inflammatory Disorders research growing?
Output in 2018–2022 was 35% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Autoimmune and Inflammatory Disorders.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.